Drug Type Small molecule-drug conjugates |
Synonyms- |
Target |
Mechanism αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 01 Jul 2021 | |
Breast Cancer | Preclinical | DE | 01 Jul 2021 | |
Breast Cancer | Preclinical | DE | 01 Jul 2021 | |
Colonic Cancer | Preclinical | US | 01 Jul 2021 | |
Colonic Cancer | Preclinical | DE | 01 Jul 2021 | |
Colonic Cancer | Preclinical | DE | 01 Jul 2021 | |
Lung Cancer | Preclinical | US | 01 Jul 2021 | |
Lung Cancer | Preclinical | DE | 01 Jul 2021 | |
Lung Cancer | Preclinical | DE | 01 Jul 2021 |